MULTICENTER STUDY ON THE USE OFGEMCITABINE TO PREVENT RECCURENCE OF MULTIPLE-RECCURING SUPERFICIAL BLADDER TUMORS FOLLOWING INTRAVESCICAL ANTIBLASTIC AGENTS AND/OR BCG: EVALUATION OF TOLERANCE